Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2025
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited held its 26th Annual General Meeting on September 27, 2025, in Vadodara, chaired by Chairman and Managing Director Mr. Falgun V. Savani. The meeting ran from 11:00 AM to 12:20 PM with 42 shareholders present out of 14,498 total shareholders on record. During his speech, the Chairman shared FY25 financial highlights: total revenue grew to ₹10,312.38 lakh from ₹9,588.27 lakh in FY24, while net profit dipped slightly to ₹1,335.79 lakh from ₹1,450.10 lakh, and profit before tax fell to ₹1,792.29 lakh from ₹1,951.66 lakh due to higher material costs. The CEO also gave a presentation on balance sheet, profit & loss, and cash flow figures. No qualifications or adverse remarks were noted in the statutory auditors' report. Voting on resolutions was conducted via remote e-voting and ballot paper, with results to be declared later by the Company Secretary.
This is a routine procedural filing confirming the AGM was held without audit issues. The slight decline in net profit and PBT despite revenue growth may be a minor concern for shareholders, but overall financials remain healthy with no red flags raised by auditors.